GlassScriptPhysician profile
David A Chesnutt
NPI 1538171061
$781.46
in general payments reported to CMS, 2019-2025
13 companies · $493 in 2025
The $493 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.50 · 2022: $16.95 · 2023: $30.11 · 2024: $161 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $363.34 | 2024-2025 | |
| Tarsus Pharmaceuticals, INC. | $113.13 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $45.07 | 2025 | Vyzulta, Miebo, Xiidra |
| Alcon Vision LLC | $41.93 | 2022-2024 | Hydrus Microstent |
| Oyster Point Pharma, INC. | $38.63 | 2023-2025 | Tyrvaya |
| Merz North America, INC. | $34.04 | 2019 | |
| Mallinckrodt Hospital Products INC. | $32.45 | 2025 | Acthar |
| Horizon Therapeutics Plc | $29.28 | 2019-2023 | Tepezza |
| Sun Pharmaceutical Industries INC. | $21.23 | 2025 | |
| Dompe US, INC. | $19.24 | 2019 | |
| Rxsight INC | $17.31 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Conmed Corporation | $14.93 | 2025 | Visiclear |
| Aerie Pharmaceuticals, INC. | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Chesnutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.